A Study of Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer

Clinical Trial ID NCT01130337

PubWeight™ 12.81^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01130337

Top papers